Publication: 2229

Publication: 2229

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Clin Cancer Res vol 21 (23) 5294-5304

Year:: 2015
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:: 2130 is parent abstract

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 5

Parents:: 1003
Children:: None

Program:: TRP
Primary Committee:: Correl Sci NOS
Sec. Committees:: Correl Sci NOS

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, CA33601, U10 CA031946, U10 CA033601, U10 CA180821, U24 CA114740, CA-114740, CA-25224, U10 CA180850, K05 CA-142885, U10 CA180790, P30 CA015083, U10 CA180882, U24 CA196171, K05 CA142885, U10 CA025224, CA31946

Corr. Author:
Authors:: Frank A. Sinicrope Michelle R. Mahoney Harry H. Yoon Thomas C. Smyrk Stephen N. Thibodeau Richard M. Goldberg Garth D. Nelson Daniel J. Sargent Steven R. Alberts

Networks:: LAPS-MN026, LAPS-OH007

Study: NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: colon cancer, adjuvant, tumor site, BRAF, KRAS, MSI, prognosis